US Broker Ratings

Tenet Healthcare Corporation (THC) Stock Analysis: Strong Buy Ratings and Promising Growth Potential

Tenet Healthcare Corporation (NYSE: THC), a major player in the United States healthcare sector, is capturing investor attention with its robust market performance and promising growth..

Axsome Therapeutics, Inc. (AXSM) Stock Analysis: Unveiling a 37.59% Potential Upside in CNS Therapy Innovations

Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company rooted in the healthcare sector, is making waves in the biotechnology industry with its innovative therapies targeting central..

Integer Holdings Corporation (ITGR) Stock Report: Navigating a 17.95% Upside Potential

Integer Holdings Corporation (NYSE: ITGR) is a key player in the healthcare sector, specifically within the medical devices industry. With a market capitalization of $2.55 billion,..

Viatris Inc. (VTRS) Stock Analysis: Exploring a 15.94% Potential Upside Amidst Dividend Strength and Challenges

Viatris Inc. (NASDAQ: VTRS) presents an intriguing opportunity for investors with its potential upside of 15.94%, a robust dividend yield of 4.64%, and a portfolio that..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Unveiling a 14% Upside Potential

Krystal Biotech, Inc. (NASDAQ: KRYS) continues to draw attention in the competitive biotechnology sector for its innovative genetic medicines targeting diseases with significant unmet medical needs...

Johnson & Johnson (JNJ) Stock Analysis: Evaluating Its 4.24% Potential Upside and Robust Dividend Yield

Johnson & Johnson (NYSE: JNJ), a stalwart in the healthcare sector, continues to capture the attention of investors with its expansive portfolio and substantial market presence...

Takeda Pharmaceutical Company L (TAK) Stock Analysis: Exploring a 27% Potential Upside

For investors eyeing the healthcare sector, Takeda Pharmaceutical Company Limited (NYSE: TAK) presents an intriguing opportunity. With a market capitalization of $44.45 billion, this Tokyo-based pharmaceutical..

ADMA Biologics Inc (ADMA) Stock Analysis: Exploring a 79.51% Potential Upside in the Biotechnology Sector

In the dynamic landscape of the biotechnology sector, ADMA Biologics Inc (NASDAQ: ADMA) emerges as a compelling player with a substantial market capitalization of $3.62 billion...

Avidity Biosciences, Inc. (RNA) Stock Analysis: Unraveling a 40% Upside Potential in the Biotech Arena

Avidity Biosciences, Inc. (NASDAQ: RNA) is at the forefront of innovation in the biotechnology sector, leveraging its distinctive RNA therapeutic platform to address diseases previously deemed..

Sarepta Therapeutics, Inc. (SRPT) Stock Analysis: Unveiling Growth Potential Amidst Biotech Challenges

Sarepta Therapeutics, Inc. (NASDAQ: SRPT) stands as a notable player in the healthcare sector, operating within the biotechnology industry. With a market capitalisation of $2.39 billion,..

Jazz Pharmaceuticals (JAZZ) Stock Analysis: A 35.8% Upside Potential Amidst Robust Buy Ratings

Jazz Pharmaceuticals plc (NASDAQ: JAZZ), a prominent player in the Biotechnology industry, continues to capture investor interest with its innovative pharmaceutical products and promising development pipeline...

UnitedHealth Group (UNH) Stock Analysis: Navigating Healthcare Growth with a 1.67% Potential Upside

UnitedHealth Group Incorporated (NYSE: UNH), a titan in the healthcare plans industry, continues to capture investor attention with its robust market presence and strategic growth initiatives...

Haleon plc (HLN) Stock Analysis: Unpacking a 25.84% Potential Upside for Investors

Haleon plc (NYSE: HLN), a prominent player in the healthcare sector, has caught the eye of investors with its robust lineup of consumer healthcare products and..

RadNet, Inc. (RDNT) Investor Outlook: Analyzing Growth Potential Amid a Competitive Healthcare Landscape

RadNet, Inc. (NASDAQ: RDNT) stands as a formidable player in the Healthcare sector, specifically within the Diagnostics & Research industry. With its headquarters in Los Angeles,..

Pfizer, Inc. (PFE) Stock Analysis: Navigating a 16.35% Potential Upside with a Strong Dividend Yield

Pfizer, Inc. (NYSE: PFE) remains a formidable player in the healthcare sector, known for its robust portfolio of biopharmaceutical products and pioneering vaccine development. With a..

TG Therapeutics, Inc. (TGTX) Stock Analysis: A Biotechnology Gem with 30.71% Potential Upside

TG Therapeutics, Inc. (NASDAQ: TGTX) is a compelling player in the biotechnology sector, particularly for investors looking for growth opportunities within the healthcare industry. With a..

Bausch + Lomb (BLCO) Investor Outlook: Navigating Through Growth and Challenges

Bausch + Lomb Corporation (NYSE: BLCO), a stalwart in the eye health sector, continues to capture the attention of investors with its extensive portfolio of products..

Koninklijke Philips N.V. (PHG): Investor Outlook on Its 15.59% Upside Potential

Koninklijke Philips N.V. (PHG) offers a compelling opportunity for investors seeking exposure in the healthcare sector, particularly within the medical devices industry. With a market capitalization..

Neurocrine Biosciences, Inc. (NBIX): Investor Outlook with an 18% Potential Upside

Neurocrine Biosciences, Inc. (NASDAQ: NBIX) stands as a compelling figure in the healthcare sector, specifically within the niche of specialty and generic drug manufacturing. With a..

Edwards Lifesciences Corporation (EW) Stock Analysis: Exploring a 14.5% Potential Upside in the Medical Devices Sector

Edwards Lifesciences Corporation (NYSE: EW), a stalwart in the medical devices sector, stands out in the healthcare industry with its innovative cardiovascular products aimed at treating..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds